The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Neuropeptide Y: A Novel Angiogenic Factor From the Sympathetic Nerves and Endothelium
Abstract
Abstract —Sympathetic nerves have long been suspected of trophic activity, but the nature of their angiogenic factor has not been determined. Neuropeptide Y (NPY), a sympathetic cotransmitter, is the most abundant peptide in the heart and the brain. It is released during nerve activation and ischemia and causes vasoconstriction and smooth muscle cell proliferation. Here we report the first evidence that NPY is angiogenic. At low physiological concentrations, in vitro, it promotes vessel sprouting and adhesion, migration, proliferation, and capillary tube formation by human endothelial cells. In vivo, in a murine angiogenic assay, NPY is angiogenic and is as potent as a basic fibroblast growth factor. The NPY action is specific and is mediated by Y1 and Y2 receptors. The expression of both receptors is upregulated during cell growth; however, Y2 appears to be the main NPY angiogenic receptor. Its upregulation parallels the NPY-induced capillary tube formation on reconstituted basement membrane (Matrigel); the Y2 agonist mimics the tube-forming activity of NPY, whereas the Y2 antagonist blocks it. Endothelium contains not only NPY receptors but also peptide itself, its mRNA, and the “NPY-converting enzyme” dipeptidyl peptidase IV (both protein and mRNA), which terminates the Y1 activity of NPY and cleaves the Tyr 1 -Pro 2 from NPY to form an angiogenic Y2 agonist, NPY 3–36 . Endothelium is thus not only the site of action of NPY but also the origin of the autocrine NPY system, which, together with the sympathetic nerves, may be important in angiogenesis during tissue development and repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Peptide Growth Factors and Their Receptors
Arai, K., Battey, J. F., Sporn, M. B., & Roberts, A. B. (1991) · Medical Entomology and Zoology · Cited by 1,225
Kubota, Y., Kleinman, H. K., Martin, G. R., & Lawley, T. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1589 · Cited by 1,209
Self-citationA receptor subtype involved in neuropeptide-Y-induced food intake
Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl-Hartmann, C., Smith, K. E., Vaysse, P., Durkin, M. M., Laz, T. M., Linemeyer, D. L., et al. (1996) · Nature · doi:10.1038/382168a0 · Cited by 891
Passaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Self-citationGrant, D. S., Tashiro, K.-I., Segui-Real, B., Yamada, Y., Martin, G. R., & Kleinman, H. K. (1989) · Cell · doi:10.1016/0092-8674(89)90945-8 · Cited by 740
Self-citationNicosia, R. F., & Ottinetti, A. (1990) · PubMed · Cited by 597
Molecular mechanisms of blood vessel formation
Bussolino, F., Mantovani, A., & Persico, G. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01074-8 · Cited by 470
Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
Larhammar, D., Blomqvist, A. G., Yee, F., Jazin, E., Yoo, H., & Wahlested, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49854-2 · Cited by 422
Bard, J. A., Walker, M. W., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26762 · Cited by 376
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
Rudolf, K., Eberlein, W., Engel, W., Wieland, H. A., Willim, K. D., Entzeroth, M., Wienen, W., Beck-Sickinger, A. G., & Doods, H. N. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90822-2 · Cited by 374
Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV
Mentlein, R., Dahms, P., Grandt, D., & Krüger, R. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90435-b · Cited by 349
The Biology of Neuropeptide Y and Related Peptides
(1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8 · Cited by 338
Higuchi, H., Yang, H. Y., & Sabol, S. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68784-8 · Cited by 311
Chemokines, inflammation and the immune system.
Taub, D. D., & Oppenheim, J. J. (1994) · PubMed · Cited by 294
Cloning and Expression of a Novel Neuropeptide Y Receptor
Weinberg, D. H., Sirinathsinghji, D. J. S., Tan, C. P., Shiao, L.-L., Morin, N., Rigby, M. R., Heavens, R. H., Rapoport, D. R., Bayne, M. L., Cascieri, M. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16435 · Cited by 275
Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y Receptor
Rose, P. M., Fernandes, P., Lynch, J. S., Frazier, S. T., Fisher, S. M., Kodukula, K., Kienzle, B., & Seethala, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22661 · Cited by 265
Co-release of neuropeptide Y and catecholamines during physical exercise in man
Lundberg, J. M., Martinsson, A., Hemsén, A., Theodorsson-Norheim, E., Svedenhag, J., Ekblom, B., & Hjemdahl, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91837-6 · Cited by 224
Grant, D. S., Kinsella, J. L., Fridman, R., Auerbach, R., Piasecki, B. A., Yamada, Y., Zain, M., & Kleinman, H. K. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530324 · Cited by 201
Self-citationGrowth‐stimulating effect of catecholamines on rat aortic smooth muscle cells in culture
Blaes, N., & Boissel, J. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041160207 · Cited by 169
Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro
Grant, D. S., Lelkes, P. I., Fukuda, K., & Kleinman, H. K. (1991) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02630910 · Cited by 138
Self-citationBell, L. B., & Madri, J. A. (1989) · Circulation Research · doi:10.1161/01.res.65.4.1057 · Cited by 131
Origin and Actions of Neuropeptide Y in the Cardiovascular System
Żukowska-Grójec, Z., & Wahlestedt, C. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8_8 · Cited by 117
Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells
Żukowska-Grójec, Z., Pruszczyk, P., Colton, C. A., Yao, J., Shen, G. H., Myers, A. K., & Wahlestedt, C. (1993) · Peptides · doi:10.1016/0196-9781(93)90040-n · Cited by 110
la Fuente, M. D., Bernaez, I., Rio, M. D., & Hernánz, Á. (1993) · PubMed Central · Cited by 106
Neuropeptide Y and Drug Development
(1997) · Elsevier eBooks · doi:10.1016/b978-0-12-304990-2.x5000-8 · Cited by 89
Johnson, R. C., Zhu, D., Augustin, H. G., & Pauli, B. U. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.121.6.1423 · Cited by 89
Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors
Żukowska-Grójec, Z., Dayao, E. K., Karwatowska‐Prokopczuk, E., Hauser, G. J., & Doods, H. N. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.2.h796 · Cited by 83
Self-citationRelease of immunoreactive-neuropeptide Y by rat platelets
Myers, A. K., Farhat, M. Y., Vaz, C. A., Keiser, H. R., & Żukowska-Grójec, Z. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81057-x · Cited by 74
̈der, C. R., Schwarzer, C., Vezzani, A., Gobbi, M., Mennini, T., & Sperk, G. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00332-d · Cited by 71
Klagsbrun, M., & Folkman, J. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74781-6_19 · Cited by 69
Characterization of a Selective Antagonist of Neuropeptide Y at the Y2 Receptor
Grouzmann, E., Buclin, T., Martire, M., Cannizzaro, C., Dörner, B., Razaname, A., & Mutter, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7699 · Cited by 56
Self-citationOkazaki, M., Hu, Z., Fujinaga, M., & Hoffman, B. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117309 · Cited by 50
Co‐release of neuropeptide Y (NPY)‐like immunoreactivity and catecholamines in newborn infants
Lundberg, J. M., Hemsén, A., Fried, G. M., THEODORSSON‐NORHEIM, E., & Lagercrantz, H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07842.x · Cited by 46
Multiple receptors and multiple actions
Grundemar, L. (1997) · Elsevier eBooks · doi:10.1016/b978-012304990-2/50002-0 · Cited by 41
Cited by
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
CD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
Pericellular Proteases in Angiogenesis and Vasculogenesis
van Hinsbergh, V. W. M., Engelse, M. A., & Quax, P. H. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209518.58252.17 · Cited by 389
Metadata
- Authors
- Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W.-T., Kleinman, H. K., Grouzmann, E., & Grant, D. S.
- Venue
- Circulation Research
- Published
- 1998-07-27
- Volume
- 83
- Issue
- 2
- Pages
- 187-195
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2096464209
- Cited by
- 378
- References
- 36
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.